Healthcare provider profile · identity verified

Christine Eun Jin Choo, MD

Internal Medicine · CLACKAMAS, OR · NPI 1932215951

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Losartan Potassium	Losartan Potassium	379	111
Atorvastatin Calcium	Atorvastatin Calcium	371	105
Amlodipine Besylate	Amlodipine Besylate	241	73
Levothyroxine Sodium	Levothyroxine Sodium	232	59
Lisinopril	Lisinopril	229	71
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	180	28
Metoprolol Tartrate	Metoprolol Tartrate	142	37
Simvastatin	Simvastatin	129	35
Gabapentin	Gabapentin	126	35
Trazodone Hcl	Trazodone Hcl	125	33
Metoprolol Succinate	Metoprolol Succinate	123	34
Potassium Chloride	Potassium Chloride	116	35
Metformin Hcl Er	Metformin Hcl	109	32
Pradaxa	Dabigatran Etexilate Mesylate	99	31
Fluoxetine Hcl	Fluoxetine Hcl	95	25
Albuterol Sulfate Hfa	Albuterol Sulfate	93	31
Pantoprazole Sodium	Pantoprazole Sodium	82	35
Omeprazole	Omeprazole	80	18
Metformin Hcl	Metformin Hcl	79	23
Furosemide	Furosemide	75	31
Oxycodone Hcl	Oxycodone Hcl	75	21
Rosuvastatin Calcium	Rosuvastatin Calcium	74	21
Pravastatin Sodium	Pravastatin Sodium	73	22
Spironolactone	Spironolactone	72	25
Atenolol	Atenolol	71	19
Donepezil Hcl	Donepezil Hcl	69	15
Mirtazapine	Mirtazapine	68	19
Tamsulosin Hcl	Tamsulosin Hcl	66	18
Glipizide	Glipizide	65	19
Duloxetine Hcl	Duloxetine Hcl	63	23
Sumatriptan Succinate	Sumatriptan Succinate	63	suppressed
Jardiance	Empagliflozin	56	16
Ondansetron Odt	Ondansetron	56	suppressed
Estradiol	Estradiol	51	26
Buspirone Hcl	Buspirone Hcl	48	suppressed
Humulin N	Insulin Nph Human Isophane	48	15
Hydrochlorothiazide	Hydrochlorothiazide	48	17
Ozempic	Semaglutide	44	suppressed
Xarelto	Rivaroxaban	43	suppressed
Meloxicam	Meloxicam	42	17
Warfarin Sodium	Warfarin Sodium	42	11
Clopidogrel	Clopidogrel Bisulfate	41	12
Allopurinol	Allopurinol	40	13
Pregabalin	Pregabalin	39	suppressed
Torsemide	Torsemide	39	12
Prednisone	Prednisone	38	15
Diazepam	Diazepam	37	suppressed
Tramadol Hcl	Tramadol Hcl	37	suppressed
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	35	12
Wixela Inhub	Fluticasone Propion/Salmeterol	35	suppressed
Nystatin	Nystatin	34	12
Memantine Hcl	Memantine Hcl	32	suppressed
Montelukast Sodium	Montelukast Sodium	32	11
Humulin R	Insulin Regular, Human	31	suppressed
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	31	suppressed
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	31	11
Propranolol Hcl	Propranolol Hcl	30	suppressed
Colestipol Hcl	Colestipol Hcl	29	suppressed
Fluticasone Propionate	Fluticasone Propionate	29	suppressed
Sertraline Hcl	Sertraline Hcl	29	suppressed
Finasteride	Finasteride	28	suppressed
Fluoridex	Fluoride (Sodium)	28	suppressed
Quetiapine Fumarate	Quetiapine Fumarate	28	suppressed
Triamcinolone Acetonide	Triamcinolone Acetonide	28	11
Alvesco	Ciclesonide	27	suppressed
Ipratropium Bromide	Ipratropium Bromide	27	13
Lorazepam	Lorazepam	27	suppressed
Nitroglycerin	Nitroglycerin	27	16
Alendronate Sodium	Alendronate Sodium	26	suppressed
Citalopram Hbr	Citalopram Hydrobromide	25	suppressed
Morphine Sulfate Er	Morphine Sulfate	25	suppressed
Veo Insulin Syringe	Syringe And Needle,insulin,1ml	25	suppressed
Veo Insulin Syringe	Syringe-Needle,insulin,0.5 Ml	25	suppressed
Pramipexole Dihydrochloride	Pramipexole Di-Hcl	24	suppressed
Terazosin Hcl	Terazosin Hcl	24	suppressed
Promethazine Hcl	Promethazine Hcl	23	suppressed
Bupropion Hcl Sr	Bupropion Hcl	22	suppressed
Bupropion Xl	Bupropion Hcl	22	suppressed
Escitalopram Oxalate	Escitalopram Oxalate	22	suppressed
Hydralazine Hcl	Hydralazine Hcl	22	suppressed
Lovastatin	Lovastatin	22	suppressed
Probenecid-Colchicine	Probenecid/Colchicine	22	suppressed
Clonidine Hcl	Clonidine Hcl	21	suppressed
Oxycodone-Acetaminophen	Oxycodone Hcl/Acetaminophen	21	suppressed
Doxazosin Mesylate	Doxazosin Mesylate	20	suppressed
Famotidine	Famotidine	20	suppressed
Insulin Glargine-Yfgn	Insulin Glargine-Yfgn	20	suppressed
Isosorbide Mononitrate Er	Isosorbide Mononitrate	20	suppressed
Ketoconazole	Ketoconazole	20	suppressed
Levetiracetam	Levetiracetam	18	suppressed
Temazepam	Temazepam	18	suppressed
Spiriva Respimat	Tiotropium Bromide	17	suppressed
Trospium Chloride	Trospium Chloride	17	suppressed
Zolpidem Tartrate	Zolpidem Tartrate	17	suppressed
Bupropion Hcl	Bupropion Hcl	16	suppressed
Sucralfate	Sucralfate	16	suppressed
Venlafaxine Hcl Er	Venlafaxine Hcl	16	suppressed
Acyclovir	Acyclovir	15	suppressed
Oxybutynin Chloride Er	Oxybutynin Chloride	15	suppressed
Prazosin Hcl	Prazosin Hcl	15	suppressed
Valacyclovir	Valacyclovir Hcl	15	suppressed
Carvedilol	Carvedilol	14	suppressed
Chlorthalidone	Chlorthalidone	14	suppressed
Digoxin	Digoxin	14	suppressed
Doxycycline Monohydrate	Doxycycline Monohydrate	13	suppressed
Estring	Estradiol	13	suppressed
Hydrocortisone	Hydrocortisone	13	suppressed
Metronidazole	Metronidazole	13	suppressed
Oxycontin	Oxycodone Hcl	13	suppressed
Veo Insulin Syringe	Syring-Needl,disp,insul,0.3 Ml	13	suppressed
Celecoxib	Celecoxib	12	suppressed
Divalproex Sodium	Divalproex Sodium	12	suppressed
Eliquis	Apixaban	12	suppressed
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	12	suppressed
Pioglitazone Hcl	Pioglitazone Hcl	12	suppressed
Amoxicillin	Amoxicillin	11	suppressed
Clonazepam	Clonazepam	11	suppressed
Morphine Sulfate	Morphine Sulfate	11	suppressed
Naproxen	Naproxen	11	suppressed
Sulfamethoxazole-Trimethoprim	Sulfamethoxazole/Trimethoprim	11	suppressed
Topiramate	Topiramate	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error